Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis

Caroline S. Clarke (), Mariya Melnychuk, Angus I. G. Ramsay, Cecilia Vindrola-Padros, Claire Levermore, Ravi Barod, Axel Bex, John Hines, Muntzer M. Mughal, Kathy Pritchard-Jones, Maxine Tran, David C. Shackley, Stephen Morris, Naomi J. Fulop and Rachael M. Hunter
Additional contact information
Caroline S. Clarke: University College London
Mariya Melnychuk: University College London
Angus I. G. Ramsay: University College London
Cecilia Vindrola-Padros: University College London
Claire Levermore: Our Future Health
Ravi Barod: Royal Free London NHS Foundation Trust
Axel Bex: University College London
John Hines: University College London Hospitals NHS Foundation Trust
Muntzer M. Mughal: University College London Hospitals NHS Foundation Trust
Kathy Pritchard-Jones: University College London Hospitals NHS Foundation Trust
Maxine Tran: Royal Free Hospital
David C. Shackley: (hosted by) Christie NHS Foundation Trust
Stephen Morris: University of Cambridge
Naomi J. Fulop: University College London
Rachael M. Hunter: University College London

Applied Health Economics and Health Policy, 2022, vol. 20, issue 6, No 11, 905-917

Abstract: Abstract Background Studies have shown that centralising surgical treatment for some cancers can improve patient outcomes, but there is limited evidence of the impact on costs or health-related quality of life. Objectives We report the results of a cost-utility analysis of the RESPECT-21 study using difference-in-differences, which investigated the reconfiguration of specialist surgery services for four cancers in an area of London, compared to the Rest of England (ROE). Methods Electronic health records data were obtained from the National Cancer Registration and Analysis Service for patients diagnosed with one of the four cancers of interest between 2012 and 2017. The analysis for each tumour type used a short-term decision tree followed by a 10-year Markov model with 6-monthly cycles. Costs were calculated by applying National Health Service (NHS) Reference Costs to patient-level hospital resource use and supplemented with published data. Cancer-specific preference-based health-related quality-of-life values were obtained from the literature to calculate quality-adjusted life-years (QALYs). Total costs and QALYs were calculated before and after the reconfiguration, in the London Cancer (LC) area and in ROE, and probabilistic sensitivity analysis was performed to illustrate the uncertainty in the results. Results At a threshold of £30,000/QALY gained, LC reconfiguration of prostate cancer surgery services had a 79% probability of having been cost-effective compared to non-reconfigured services using difference-in-differences. The oesophago-gastric, bladder and renal reconfigurations had probabilities of 62%, 49% and 12%, respectively, of being cost-effective at the same threshold. Costs and QALYs per surgical patient increased over time for all cancers across both regions to varying degrees. Bladder cancer surgery had the smallest patient numbers and changes in costs, and QALYs were not significant. The largest improvement in outcomes was in renal cancer surgery in ROE, making the relative renal improvements in LC appear modest, and the probability of the LC reconfiguration having been cost-effective low. Conclusions Prostate cancer reconfigurations had the highest probability of being cost-effective. It is not clear, however, whether the prostate results can be considered in isolation, given the reconfigurations occurred simultaneously with other system changes, and healthcare delivery in the NHS is highly networked and collaborative. Routine collection of quality-of-life measures such as the EQ-5D-5L would have improved the analysis.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40258-022-00745-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:20:y:2022:i:6:d:10.1007_s40258-022-00745-w

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-022-00745-w

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().